QNCX
Quince Therapeutics, Inc.
31.00$
+3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.42 | 0.47 | 1.98 | 2.28 | 2.32 | 1.04 | 1.73 | 0.86 | 0.57 | |
| -0.42 | -0.47 | -1.98 | -2.28 | -2.32 | -1.04 | -1.73 | -0.86 | -0.57 | |
| 84.44 | 93.59 | 317.51 | 420.25 | 409.14 | 150.33 | 50.74 | 85.94 | 141.25 | |
| 11.80 | 18.88 | 94.09 | 120.55 | 198.68 | 155.31 | 95.04 | 81.27 | 60.07 | |
| 96.24 | 112.47 | 411.60 | 540.80 | 607.82 | 310.57 | 185.94 | 264.83 | 200.76 | |
| -96.24 | -112.47 | -411.60 | -540.80 | -607.82 | -310.57 | -185.94 | -264.83 | -201.33 | |
| 15.25 | 8.88 | 22.99 | 14.01 | 2.51 | 3.39 | – | – | – | |
| -113.54 | -115.78 | -388.61 | -526.79 | -605.31 | -310.14 | -169.63 | -262.31 | -322.43 | |
| 17.31 | 3.31 | -1.98 | 14.87 | -4.17 | -1.70 | -1.06 | 0.40 | 12.83 | |
| -113.54 | -115.78 | -388.61 | -526.79 | -605.31 | -308.45 | -168.57 | -262.71 | -335.27 | |
| -95.82 | -111.99 | -409.63 | -538.53 | -603.00 | -304.42 | -144.05 | -166.35 | -321.87 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.